• SENSEX 73,377.24
    -229.51 (--0.31%)
  • BANKNIFTY 54,366.70
    79.35 (+0.15%)
  • TVS Holdings
    11,337.15 16,150.00(%)
  • NSE
    1,774.00 1,878.00(%)
  • Ather Energy
    1,702.00 1,741.90(%)
  • Apollo Micro Sys
    446.80 466.70(%)
  • LIC Housing Fin.
    512.00 598.00(%)
  • DLF
    672.55 786.40(%)
  • Persistent Systems
    5,695.50 4,242.65(%)
  • Sona BLW Precis.
    863.90 843.90(%)
  • Adani Enterp.
    2,431.85 1,753.45(%)
  • Federal Bank
    348.20 364.95(%)
  • Reliance Industries
    1,184.00 1,152.30(%)
  • OneSource Speci.
    1,606.35 1,924.00(%)
  • Sky Gold & Diam.
    965.00 1,083.00(%)
  • HDFC Bank
    680.10 682.00(%)
  • SBI Life Insuran
    1,626.75 1,609.20(%)
  • Torrent Pharma.
    4,649.20 5,249.95(%)
  • Tonbo Imaging
    1,300.00 1,331.45(%)
  • Max Healthcare
    857.00 1,196.50(%)
  • GE Vernova T&D
    4,025.00 5,650.00(%)
  • NTPC
    306.70 414.40(%)
  • Overview
  • Key Ratios
  • Financials
  • Shareholding
  • Company Info
  • Peer Comparison

Aurobindo Pharma Ltd Pharmaceuticals - Indian - Bulk Drugs & Formln

  • Indian Private
  • BSE Code : 4666.0
  • ISIN : INE406A01037
1,590.00 18 (1.16%)
  • As on 27 Oct 2026 (EOD)
  • Today’s Low

    1,553.00
  • Today’s High

    1,591.30
  • Open

    1,562.40
  • Perv Close

    1,571.70
  • 52W Low

    1,081.40
  • 52W High

    1,740.00

Key Indicators

  • P/E(TTM)

    35.11

  • Mar.Cap (₹Cr.)

    91,485.09

  • Div & Yield %

    0.25

  • Book Value(₹)

    394.82

  • Debt-Equity Ratio

    1.16

  • AGM Date

    26-Oct-2026

  • EPS

    45.29

  • P/E Ratio

    35.11

Financials Ratios

  • Debt-Equity Ratio

    0.21

  • Mar.Cap (₹Cr.)

    91,485.09

  • RONW (%)

    11.18

  • ROCE (%)

    13.51

Score Board

  • Equity (₹ in Cr.)

    57.54

  • BV (₹)

    394.80

  • Sales( ₹ in Cr.)

    11,171.72

  • NP (in Cr.)

    2,426.73

  • NP Var(%)

    40.0

  • Div%

    400.0

  • CPS (₹)

    47.10

  • EPS (₹)

    42.20

  • Traded Value (₹ in Lakhs)

    91,485.09

  • 52 Week High

    1,740.00

  • 52 Week Low

    1,081.40

  • Price BSE

    1590.0

  • Price NSE

    1,590.00

  • Market Capital( in Cr.)

    91,485.09

  • P/C Ratio

    33.70

  • P/E Ratio

    37.70

  • Price Vs.BV

    42.20

View More
Invest Now!

Navigate The Market With Confidence

Your all-in-one destination for expert investment guidance and streamlined portfolio management solutions

Financials

All Values are in (₹Cr)
Particulars(INCOME) 2026 Mar 2025 Mar 2024 Mar 2023 Mar 2022 Mar 2021 Mar
INCOME :            
Sales Turnover 11,171.72 10,933.30 10,645.64 8,457.00 11,287.14 15,823.68
Excise Duty 0.00 0.00 0.00 0.00 0.00 0.00
Net Sales 11,171.72 10,933.30 10,645.64 8,457.00 11,287.14 15,823.68
Other Income 587.53 328.12 670.10 443.92 670.99 589.86
Stock Adjustments -46.55 67.66 116.23 263.95 -45.51 -2.99
Total Income 11,712.70 11,329.08 11,431.97 9,164.87 11,912.62 16,410.55
EXPENDITURE :            
Raw Materials 5,311.58 5,675.34 5,964.48 4,755.95 5,800.74 7,241.83
Power and Fuel Cost 174.82 185.59 191.58 167.86 477.99 512.34
Employee Cost 1,161.15 1,063.07 980.56 890.53 1,600.04 1,735.42
Other Manufacturing Expenses 421.52 426.63 414.51 328.42 705.68 925.86
Selling and Administration Expenses 873.42 960.27 822.21 939.38 1,009.36 1,069.84
Miscellaneous Expenses 108.12 132.49 164.49 148.96 249.13 215.57
Employee Benefit Expenses 1,161.15 1,063.07 980.56 890.53 1,600.04 1,735.42
Less: Preoperative Expenditure 0.00 0.00 0.00 0.00 0.00 0.00
Total Expenses 8,050.61 8,443.39 8,537.83 7,231.10 9,842.94 11,700.86
Operating Profit 3,662.09 2,885.69 2,894.14 1,933.77 2,069.68 4,709.69
Interest 213.15 230.04 182.60 74.58 16.94 28.68
Gross Profit 3,448.94 2,655.65 2,711.54 1,859.19 2,052.74 4,681.01
Depreciation 285.36 297.20 254.58 243.26 415.26 488.00
Profit Before Tax 3,163.58 2,358.45 2,456.96 1,615.93 1,637.48 4,193.01
Current Tax 746.82 627.37 598.08 412.16 379.70 1,043.34
Fringe Benefit tax 0.00 0.00 0.00 0.00 0.00 0.00
Deferred Tax 1.96 -15.71 -95.26 -23.34 -196.93 36.76
Reported Net Profit 2,414.80 1,746.79 1,954.14 1,227.11 1,454.71 3,112.91
Extraordinary Items -11.93 9.46 3.28 9.94 -81.27 -0.13
Adjusted Net Profit 2,426.73 1,737.33 1,950.86 1,217.17 1,535.98 3,113.04
Adjustment below Net Profit 1.08 -5.26 -1.69 8.28 1.69 -6.42
P & L Balance brought forward 20,090.40 18,348.87 16,660.08 15,864.14 14,671.41 11,799.30
Statutory Appropriations 0.00 0.00 0.00 0.00 0.00 0.00
Appropriations 232.30 0.00 263.66 439.45 263.67 234.38
P & L Balance carried down 22,273.98 20,090.40 18,348.87 16,660.08 15,864.14 14,671.41
Dividend 232.30 0.00 263.66 439.45 0.00 0.00
Preference Dividend 0.00 0.00 0.00 0.00 0.00 0.00
Equity Dividend (%) 400.00 0.00 450.00 750.00 900.00 400.00
Dividend Per Share(Rs) 4.00 0.00 4.50 7.50 9.00 4.00
Earnings Per Share-Unit Curr 41.58 30.08 33.35 20.94 24.83 53.13
Earnings Per Share(Adj)-Unit Curr 41.58 30.08 33.35 20.94 24.83 53.13
Book Value 391.14 353.55 336.62 307.80 292.15 271.80
Book Value(Adj)-Unit Curr 391.14 353.55 336.62 307.80 292.15 271.80

Shareholding Pattern

  • Promoter Group

    51.88%

  • Public Share Holding

    48.12%

Category of Shareholder No of Shares % Holdings Demat Shares Shareholders
A]. Promoter & Group
Foreign (Promoter & Group) - Bodies Corporate 0 0.00 0 0
Foreign (Promoter & Group)-Individuals (Non-Resident / Foreign) 17,690,341 17,690,341.00 17,690,341 17,690,341
Foreign Promoter(Institutional) 0 0.00 0 0
Promoter Others 0 0.00 0 0
Sub Total 17,690,341 3.07 17,690,341 1
[2] INDIAN
Bodies Corporate-Indian (Promoter & Group) 210,859,525 36.65 210,859,525 4
Government(Central / State)-Indian (Promoter & Group) 0 0.00 0 0
Directors & their Relatives-Indian (Promoter & Group) 0 0.00 0 0
Financial Institutions / Banks-Indian (Promoter & Group) 0 0.00 0 0
Individuals / Hindu Undivided Family-Indian (Promoter & Group) 69,947,860 12.16 69,947,860 9
Partnership Firms-Indian (Promoter & Group) 0 0.00 0 0
Persons Acting in Concert 0 0.00 0 0
Trusts 0 0.00 0 0
Others 0 0.00 0 0
Sub Total 280,807,385 48.80 280,807,385 13
Total ShareHolding for Promoter & Group
B]. Publice Share Holding
1] Institution
Government(Central / State) 0 0.00 0 0
Clearing Members 0 0.00 0 0
Corporate Bodies 0 0.00 0 0
Foreign Direct Investments 0 0.00 0 0
Financial Institutions / Banks 422,602 0.07 422,602 3
Foreign Bank 0 0.00 0 0
Foreign Bodies Corporate/OCBs/FBC 0 0.00 0 0
Foreign Collaborators 0 0.00 0 0
Foreign Institutional Investors 100,169,804 17.41 100,169,804 756
Foreign Venture Capital Investors 0 0.00 0 0
Foreign Institution Other 0 0.00 0 0
Insurance Companies 27,842,941 4.84 27,842,941 25
Mutual Funds / UTI 93,868,012 16.31 93,868,012 44
Individuals (Non-Resident / Foreign) 0 0.00 0 0
NSDL Intransit 0 0.00 0 0
Others 18,398,182 3.20 18,398,182 43
Trusts 0 0.00 0 0
Venture Capital Funds 0 0.00 0 0
Sub total 240,701,541 41.83 240,701,541 871
2] Non Institution
Bodies Corporate 3,414,985 0.59 3,413,875 1,661
Clearing Members 23,642 0.00 23,642 7
Directors of their Relatives 4,010 0.00 4,010 2
Employees 0 0.00 0 0
Escrow Account 0 0.00 0 0
Foreign Corporate Bodies 0 0.00 0 0
Foreign Direct Investments 0 0.00 0 0
NRIs/Foreign Individuals/Foreign Nationals 2,052,698 0.36 2,052,698 7,899
Foreign Non Institution Other 410 0.00 410 1
Hindu Undivided Families 832,155 0.14 832,155 3,630
Indian Public 0 0.00 0 0
Individuals holding nominal share capital in excess of Rs. 1 lakh 1,878,878 0.33 1,878,878 5
Individuals holding nominal share capital up to Rs. 1 lakh 27,006,390 4.69 26,438,340 219,622
Market Maker 0 0.00 0 0
NSDL Transit 0 0.00 0 0
Shares in transit 0 0.00 0 0
Societies 0 0.00 0 0
Trust & Foundation 32,255 0.01 32,255 20
Others 928,095 0.16 928,095 4
Sub Total 36,178,628 6.29 35,609,468 232,852
Total Public Shareholding
C]. Shares held by Custodians and against which Depository Receipts have been issued
ADR 0 0.00 0 0
GDR 0 0.00 0 0
Other Custodians 0 0.00 0 0
Total Shares held by Custodians and against which Depository Receipts have been issued 0 0.00 0 0
Grand Total ( A + B + C ) 575,377,895 100.00 574,808,735 233,737

Company Background

Aurobindo Pharma LtdPharmaceuticals - Indian - Bulk Drugs & Formln

  • Aurobindo Pharma Ltd
  • BSE Code : 4666.0
  • ISIN : INE406A01037
  • Incorporation Year

    1986

  • Registered Office

    Plot No 2 Maitrivihar
    Behind Maithri Vanam Ameerpet, Hyderabad,
    Telangana-500038

  • Telephone

    91-40-23736370

  • FAX

    91-40-23747340

  • Chairman

    M R Kumar

  • Managing Director

    Kambam Nityananda Reddy

  • Company Secretary

    B Adi Reddy

  • Auditor

    Deloitte Haskins & Sells

  • Face Value

    1

  • Listing

    NSE

  • Registrar

    KFin Techologies Ltd
    Karvy Selenium Tow-B,
    31&32 Financial Dist,Nanakramguda
    Mumbai - Hyderabad-500032

Aurobindo Pharma Ltd Peer Comparison

Profit & Loss
Financial Ratios
Balance Sheet
Select Company Name LTP (₹) Revenue Sales P/E Ratio ROCE %
Aurobindo Pharma 1,590.00 11,759.25 11,171.72 35.29 12.91
Abbott India 25,222.05 7,217.19 6,929.05 33.19 43.78
Astrazeneca Phar 6,074.75 2,304.07 2,275.58 89.53 27.86
Glaxosmi. Pharma 2,448.15 3,932.76 3,790.20 39.11 58.17
Novartis India 1,788.65 393.10 354.33 45.17 15.94
Cipla 1,353.00 20,102.60 18,979.95 35.56 13.88
Bliss GVS Pharma 617.15 773.53 729.81 57.36 12.51
Amrutanjan Healt 490.00 520.13 502.55 26.25 24.16
Fermenta Biotec. 445.65 474.15 450.25 20.81 18.77
Guj. Themis Bio. 337.75 168.25 165.82 90.31 18.05
Ambalal Sarabhai 35.99 19.52 3.94 66.65 6.77